Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Efficacy, Safety, and Tolerability of Theta-Burst Stimulation in Mixed Depression: Design, Rationale, and Objectives of a Randomized, Double-Blinded, Sham-Controlled Trial

Full text
Author(s):
Tavares, Diego Freitas [1] ; Rodrigues dos Santos, Carla Garcia [1] ; Lane Valiengo, Leandro Da Costa [1] ; Klein, Izio [1] ; Borrione, Lucas [1] ; Forte, Pamela Marques [1] ; Brunoni, Andre R. [1] ; Moreno, Ricardo Alberto [1]
Total Authors: 8
Affiliation:
[1] Univ Sao Paulo, Dept Psychiat, Sao Paulo - Brazil
Total Affiliations: 1
Document type: Journal article
Source: FRONTIERS IN PSYCHIATRY; v. 11, MAY 15 2020.
Web of Science Citations: 0
Abstract

Introduction Mixed-specifier mood disorders are probably a different subgroup in terms of response to treatment, socio-demographic parameters, course, and family history. Here we describe the rationale and design of a clinical trial aimed to test the efficacy, safety, and tolerability of a non-pharmacological treatment known as theta-burst stimulation (TBS) for treating the mixed depressive episodes of both bipolar (I or II), and unipolar depression. Methods The study is designed as a randomized, sham-controlled, double-blinded clinical trial evaluating TBS for the treatment of moderate or severe major depressive episodes with mixed features of patients receiving at least one first or second-line pharmacological treatment for depressive episodes without adequate response. Ninety adult (18 to 65 years old) patients will be enrolled and submitted to 6-week (comprising 5 consecutive days a week sessions for the first 3 weeks and then 2 days a week for a further 3 week) of inhibitory followed by excitatory TBS in dorsolateral prefrontal cortex. Participants will be assessed using clinical and neuropsychological tests before and after the intervention. The primary outcome is change in Montgomery-angstrom sberg Depression Scale (MADRS) score over time and across groups. Cognitive parameters will also be assessed with neuropsychological tests. Results The clinical results will provide evidence about TBS as an adjunctive treatment for mixed depression treatment and neuropsychological parameters will contribute toward an improved understanding the effects of TBS in cognition. Conclusion Our results could introduce a novel therapeutic technique for mixed depressive episodes of both bipolar and unipolar disorders. (AU)

FAPESP's process: 17/19237-1 - Theta-Burst Stimulation efficacy, safety, and tolerability in mixed depressive episodesof bipolar and major depressive disorders.
Grantee:Ricardo Alberto Moreno
Support Opportunities: Regular Research Grants